ENVBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Enveric Biosciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.39+0.01 (+0.72%)
Close on Oct 19, 2026
- Market cap
- $5.54M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Enveric Biosciences has not reported a dividend
No dividend per share appears in Enveric Biosciences's annual filings since fiscal 2010.